S. aureus (MFP03) and S. epidermidis (MFP04) were collected from the skin of healthy volunteers46 (link). These bacteria were characterized by phenotypic, metabolic, MALDI-Biotyper proteomic analysis and 16S ribosomal RNA gene sequencing. All bacteria were grown at 37 °C in Luria-Bertani (LB) medium under gentle agitation (180 rpm). Bacteria were stored on cryobeads at −140 °C and subjected to two pre-culture phases. For the studies, bacteria collected at the end of the exponential growth phase were diluted in fresh broth. The peptides, diluted in sterile physiological water (NaCl 0.9%), or an equivalent volume of physiological water in control studies, were added at the beginning of the log growth phase. Before the tests, the bacteria were harvested by centrifugation (7,000 × g) and washed with sterile physiological water to remove any trace of free peptide. The bacterial density and the absence of contamination were controlled by plating. The viability of the bacteria in eukaryotic cell culture medium and under different culture conditions was controlled in preliminary studies (data not shown). CGRP and Substance P were obtained from Polypeptides (Strasbourg, France). Gadolinium chloride (GdCl3) was obtained from Sigma-Aldrich (Saint-Quentin Fallavier, France).
Free full text: Click here